Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9447166
APP PUB NO 20140329888A1
SERIAL NO

14231629

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides an intraceptor that interacts with and decreases activity of with VEGF and/or a VEGFR for the treatment of angiogenesis-related conditions. The present invention further provides pharmaceutical compositions, and methods of use thereof, for the treatment and prevention of an angiogenesis-related condition using said intraceptors. The invention further provides for nucleic acids encoding said intraceptors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTEAUGUSTA GA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ambati, Balamurali Sandy, US 9 44
Amin, Shivan Martinez, US 4 16
Singh, Nirbhai Augusta, US 5 110

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 20, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00